BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 247 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $729,000 | +4.9% | 5,000 | -14.7% | 0.25% | +30.3% |
| Q1 2022 | $695,000 | -10.9% | 5,860 | +3.5% | 0.20% | -7.6% |
| Q4 2021 | $780,000 | +24.8% | 5,660 | +25.8% | 0.21% | +17.2% |
| Q3 2021 | $625,000 | +43.0% | 4,500 | 0.0% | 0.18% | +40.6% |
| Q2 2021 | $437,000 | +41.9% | 4,500 | 0.0% | 0.13% | +30.6% |
| Q1 2021 | $308,000 | -26.1% | 4,500 | -7.6% | 0.10% | -30.5% |
| Q4 2020 | $417,000 | +42.3% | 4,870 | +8.2% | 0.14% | +17.5% |
| Q3 2020 | $293,000 | +48.7% | 4,500 | +66.7% | 0.12% | -7.0% |
| Q2 2020 | $197,000 | +20.9% | 2,700 | -10.0% | 0.13% | +53.6% |
| Q4 2019 | $163,000 | +96.4% | 3,000 | +50.0% | 0.08% | +82.6% |
| Q3 2019 | $83,000 | – | 2,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 1,111,111 | $107,867,000 | 52.60% |
| Knoll Capital Management, LLC | 856,844 | $83,182,000 | 43.44% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,082,555 | $202,174,000 | 27.86% |
| ARS Investment Partners, LLC | 558,286 | $54,198,000 | 5.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $17,113,000 | 4.52% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 401,006 | $38,930,000 | 4.51% |
| Eventide Asset Management | 1,990,797 | $193,267,000 | 2.60% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 56,626 | $5,497,000 | 2.45% |
| Avidity Partners Management LP | 882,500 | $85,673,000 | 2.32% |
| Nicholas Investment Partners, LP | 363,708 | $35,309,000 | 2.22% |